The study will determine whether Nerites novel polymer coatings can prevent biofilm growth, the source of most infections on urinary stents and catheters. Biofilms grow on the surface of the device and provide an anchor for bacteria, which then recruit other bacteria and cause infection.
Thomas Mozer, CEO and president of Nerites, said: “This money will help us test our coating technology, which we believe will block biofilm formation reliably and inexpensively, without antibiotics or biocides.”